BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24564526)

  • 1. Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.
    Zhang D; Wang G; Wang Y
    BMC Bioinformatics; 2014; 15 Suppl 2(Suppl 2):S10. PubMed ID: 24564526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
    Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
    BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
    Long X; Fan M; Bigsby RM; Nephew KP
    Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.
    Shen C; Huang Y; Liu Y; Wang G; Zhao Y; Wang Z; Teng M; Wang Y; Flockhart DA; Skaar TC; Yan P; Nephew KP; Huang TH; Li L
    BMC Syst Biol; 2011 May; 5():67. PubMed ID: 21554733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
    Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
    Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
    Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
    Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor.
    Coser KR; Wittner BS; Rosenthal NF; Collins SC; Melas A; Smith SL; Mahoney CJ; Shioda K; Isselbacher KJ; Ramaswamy S; Shioda T
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14536-41. PubMed ID: 19706540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.
    Sengupta S; Biarnes MC; Jordan VC
    Breast Cancer Res Treat; 2014 Jan; 143(1):113-24. PubMed ID: 24309997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
    van Agthoven T; Godinho MF; Wulfkuhle JD; Petricoin EF; Dorssers LC
    Int J Cancer; 2012 Nov; 131(9):1998-2007. PubMed ID: 22328489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
    Moerkens M; Zhang Y; Wester L; van de Water B; Meerman JH
    BMC Cancer; 2014 Apr; 14():283. PubMed ID: 24758408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
    Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC
    BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen induced concentration dependent differential gene expression in human breast cancer (MCF7) cells: role of transcription factors.
    Chandrasekharan S; Kandasamy KK; Dayalan P; Ramamurthy V
    Biochem Biophys Res Commun; 2013 Aug; 437(3):475-81. PubMed ID: 23845903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer.
    Jeong J; Li L; Liu Y; Nephew KP; Huang TH; Shen C
    BMC Med Genomics; 2010 Nov; 3():55. PubMed ID: 21108837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
    Wallez Y; Riedl SJ; Pasquale EB
    J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.